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osting by EAbstract Objective: Gender differences in the clinical presentation and management of patients
with acute coronary syndrome (ACS) have been reported in different parts of the world with con-
tradicting results. We aimed at investigating the presence of gender bias in patients admitted with
ACS to Aseer Central Hospital (ACH).
Methods: A retrospective cohort of all consecutive patients admitted to ACH with the diagnosis of
ACS, during the period between the 1st of June 2007 and the 31st of May 2009 was studied. Data on
demographic and clinical proﬁles, management and outcomes of ACS patients were collected and
compared for both genders.
Results: The present study included 148 females and 397 males. Females were signiﬁcantly older
than males (62.9 ± 14.2 vs. 60 ± 13.4, respectively, P< 0.03), were less likely ever to have smoked
(0.7% vs. 26.2%, respectively, P< 0.001), less likely to have had a history of hyperlipidemia
(10.8% vs. 22.2%, respectively, P< 0.003) or family history of ischemic heart disease (10.1% vs.
18.9%, respectively, P< 0.014). Female patients presented more with atypical presentation
(42.6% vs. 28.9%, respectively, P< 0.003), more with unstable angina (72.3% vs. 50.4%, respec-
tively, P< 0.001), and less with ST-elevation myocardial infarction (18.9% vs. 40.8%, respectively,
P< 0.001). Furthermore, they had signiﬁcantly lower levels of hemoglobin compared to males2418199.
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136 A.S. Assiri(12.9 ± 2.3 vs. 14.5 ± 2.2 g/L, respectively, P< 0.001), and higher levels of high density lipopro-
tein (1.1 ± 0.4 vs. 0.98 ± 0.4 mmol/L, respectively, P< 0.008). Left ventricular ejection fraction
was signiﬁcantly higher in female patients compared to males (50.9 ± 14 vs. 45.8 ± 14, respec-
tively, P< 0.003). Coronary angiography showed a higher rate of normal ﬁndings (29.3% vs.
8.9%, respectively, P< 0.001) and less severe disease (46.7% vs. 60.3%, respectively, P< 0.027)
in women, however, they were less likely to undergo invasive revascularization procedures (31%
vs. 42.8%, respectively, P< 0.013). No signiﬁcant differences were found between both sexes
regarding in-hospital mortality or re-infarction rates.
Conclusion: We documented gender differences in both clinical presentation as well as management
of patients admitted with ACS to ACH. However, there were no signiﬁcant differences between
both genders regarding the clinical in-hospital outcomes. Emphasis should be made to avoid such
bias in the future.
ª 2011 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Acute coronary syndrome is a well established major cause of
death and disability in both developed and developing coun-
tries (Lopez and Murray, 1998). Women with ACS tend to
have worse long term and short term prognosis than men with
ACS (Lagerqvist et al., 2001; Munir et al., 2010; Anand et al.,
2005; Bhatt et al., 2004; Dey et al., 2009; Aguado-Romeo et al.,
2007; El-Menyar and Al Suwaidi, 2009; El-Menyar et al., 2009;
Vaccarino et al., 2002, 2001, 2003; Boersma et al., 2002; Has-
dai et al., 2003; Fox et al., 2002). This gender difference in
prognosis is uncertain whether it is due to different baseline
characteristics or due to physiopathologic distinction between
women and men. Gender bias in the diagnosis and manage-
ment of ACS have been investigated thoroughly since Ayami-
an ﬁrst described this phenomenon in 1991 and showed that
women with ACS are less likely to undergo coronary angiog-
raphy and invasive revascularization compared to men (Aya-
nian and Epstein, 1991). Recent observational studies have
shown that recommended guidelines for management of
ACS are less frequently followed in women with ACS than
in men (El-Menyar and Al Suwaidi, 2009; Vaccarino et al.,
2005). In contrast, there are studies demonstrating no gender
differences in the management and outcomes among ACS pa-
tients (Hochman et al., 1997; Perers et al., 2005). Thus, the ef-
fect of gender on the management and outcomes of patients
with ACS remains controversial. Since Gulf RACE reported
signiﬁcant gender bias in management and outcomes of ACS
patients from six Gulf countries (including Saudi Arabia)
(El-Menyar et al., 2009), we aimed to evaluate whether gender
related differences in the presentation, management, and
in-hospital outcomes among ACS patients admitted to the
tertiary care hospital in south west region of Saudi Arabia
exist.
The Aseer region (population of 1,200,000) is located in the
southwest of Saudi Arabia covering an area of more than
80,000 km2. The region extends from the high mountains of
Sarawat (with an altitude of 3200 m above the sea level) to
the Red Sea and lies few kilometers from the northern border
of neighboring Republic of Yemen. Health services delivery in
Aseer region is provided by a network of 244 primary health
care centers, 16 referral hospitals and a 500 bed tertiary hospi-
tal – Aseer Central Hospital (ACH) run by the Ministry of
Health and the College of Medicine of King Khalid Univer-
sity, Abha.2. Methodology
2.1. Patient selection
A retrospective cohort of all consecutive patients admitted to
Aseer Central Hospital with the diagnosis of ACS for the per-
iod extending from 1st of June 2007 to 31st of May 2009 was
included. All cases of ACS above 18 years of age were included
and there was no exclusion criteria except for missing or
incomplete records. Diagnosis of the different types of ACS
was based on the American College of Cardiology clinical data
standards (Cannon et al., 2001).
2.2. Demographic data
Data were collected regarding demographic variables and cor-
onary risk factors (diabetes, hypertension, smoking, hyperlip-
idemia and family history of ischemic heart disease).
Diabetes was deﬁned as having a history of diabetes diagnosed
and/or treated with medication and/or diet or fasting blood
glucose of 7.0 mmol/L (126 mg/dL) or greater. Hypertension
was deﬁned as having a history of hypertension diagnosed
and/or treated with medication, diet, and/or exercise, blood
pressure greater than 140 mmHg systolic or 90 mmHg diastolic
on at least two occasions or receiving any antihypertensive
drug. Hyperlipidemia was deﬁned as history of dyslipidemia
diagnosed and/or treated by a physician or total cholesterol
greater than 5.18 mmol/L (200 mg/dL) or low-density lipopro-
tein greater than or equal to 3.37 mmol/L (130 mg/dL). Cur-
rent smoker was deﬁned as a person smoking cigarettes
within one month of index admission. A positive family history
for coronary artery disease was deﬁned as evidence of coro-
nary artery disease in a parent, sibling, or children before
55 years of age. The prevalence of obesity was not obtained
since the majority of patient’s records lacked data on both
weight and height which are necessary to calculate the body
mass index.
2.3. Clinical presentation and management data
Data on the presenting symptoms, admission diagnosis and
time to presentation were collected. Results of performed
investigations including laboratory tests, ECG, echocardiogra-
phy and coronary angiography performed during current
admission were collected and analyzed. Different medical
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revascularization procedure (coronary angioplasty or coronary
artery bypass graft surgery) was also recorded.
2.4. Outcome parameters
Outcome parameters evaluated during the hospital stay in-
cluded: in-hospital mortality and re-infarction rates. Re-infarc-
tion was deﬁned as a second MI during hospitalization for the
ﬁrst MI, which was determined (1) by new, signiﬁcant Q waves
inP2 leads different from those affected during initial MI; (2)
by re-elevation of CK-MB to higher levels than normal (or by
another 50% if already higher than normal); or (3) by re-eleva-
tion of CK-MB to >3 or >5 times the upper limit of normal
after angioplasty or bypass surgery, respectively (The GUS-
TO-III Investigators, 1997).
2.5. Statistical analysis
Coded data from patient’s records were analyzed using SPSS
software package. Frequency, percentage, mean, standard
deviation and median were used to present the data. Chi
square and student ‘‘t’’ were used as tests of signiﬁcance at
5% level of signiﬁcance.
Approval of the local medical – ethical committee was
obtained.
3. Results
3.1. Demographic and coronary risk factors proﬁle
A total of 545 consecutive patients with ACS were included;
397 (72.8%) were males and 148 (27.2%) were females. Table 1
shows demographic and coronary risk factors of the study co-
hort. Females were signiﬁcantly older than males (62.9 ±
14.2 years vs. 60 ± 13.4 years, respectively, P< 0.03) and
were less likely ever to have smoked (0.7% vs. 26.2%, respec-
tively, P< 0.001), less likely to have had a history of hyperlip-
idemia (10.8% vs. 22.2%, respectively, P< 0.003) or family
history of ischemic heart disease (10.1% vs. 18.9%, respec-
tively, P< 0.014). Other coronary risk factors were distrib-
uted equally.Table 1 Demographic features and coronary risk factors among th
Female
N (%) 148 (27.2%)
Age (years) Mean ± SD 62.9 ± 14.2
Nationality
Saudi 140 (94.6%)
Non-Saudi 8 (5.4%)
Coronary risk factors
Diabetes 75 (50.7%)
Hypertension 64 (43.2%)
Smoking 1 (0.7%)
Hyperlipidemia 16 (10.8%)
Family history of IHD 15 (10.1%)
* Statistically signiﬁcant difference between males and females (P< 0.053.2. Clinical presentation data
Table 2 shows different clinical presentation variables. Fe-
males tend to present more with atypical presentation (dyspnea
or symptoms other than classic chest pain), (42.6% vs. 28.9%,
respectively, P< 0.003) and signiﬁcantly have more unstable
angina (72.3% vs. 50.4%, respectively, P< 0.001) and less
ST-segment elevation MI (18.9% vs. 40.8%, respectively,
P< 0.001). No statistical signiﬁcant differences were found
between both sexes regarding the time to presentation or the
time to thrombolytic therapy when indicated.
3.3. Performed investigations
Table 3 shows different investigations performed for both
sexes. Female patients with ACS had signiﬁcantly lower level
of hemoglobin than men (12.9 ± 2.2 vs. 14.5 ± 2.2 g/dl,
respectively, P< 0.001), and higher level of high density lipo-
protein (1.1 ± 0.4 vs. 0.98 ± 0.38 mmol/L, respectively,
P< 0.05, P< 0.008).
Echocardiography was performed equally on both gender
groups, and female patients had a signiﬁcantly higher ejection
fraction (50.9 ± 14.1 vs. 45.8 ± 14, respectively, P< 0.003)
than males.
Coronary angiography was performed equally for both
gender groups, with signiﬁcantly more normal ﬁnding in wo-
men (29.3% vs. 8.9%, respectively, P< 0.001), and less severe
disease in women evident by less number of coronary arteries
involved (46.7% vs. 60.3%, respectively, P< 0.027) compared
to men.
3.4. Treatment modalities and outcomes
Table 4 shows different treatment modalities used. Most of
therapeutic agents were used equally for both gender groups,
but beta-blockers were prescribed more signiﬁcantly to female
patients with ACS compared to male patients (76.4% vs.
67.5%, respectively, P< 0.045). For patients who underwent
coronary angiography, female patients had signiﬁcantly less
chance of having invasive revascularization procedure done:
coronary angioplasty or coronary artery bypass graft surgery
(31.1% vs. 42.8%, respectively, P< 0.013).e study cohort.
Male P-Value
397 (72.8%)
60 ± 13.4* P< 0.03
349 (87.9%)* P< 0.02
48 (12.1%)
205 (51.6%) NS
148 (37.3%) NS
104 (26.2%)* P< 0.001
88 (22.2%)* P< 0.003
75 (18.9%)* P< 0.014
).
Table 2 Clinical presentations among males and females.
Females N= 148 Males N= 397 P-Value
Presenting symptoms
Typical (chest pain) 85 (57.4%) 282 (71%) NS
Atypical symptoms 63 (42.6%) 115 (28.9%)* P< 0.003
Time to presentation (h) 71.2 ± 85.5 66.7 ± 164.7 NS
Time to thrombolytics (h) 1.46 ± 0.79 1.6 ± 2.1 NS
Presenting diagnosis
Unstable angina 107 (72.3%) 200 (50.4%)* P< 0.001
ST-elevation M.I 28 (18.9%) 162 (40.8%)* P< 0.001
Non ST-elevation M.I 13 (8.8%) 35 (8.8%) NS
* Statistically signiﬁcant difference between males and females (P< 0.05).
Table 3 Performed investigations.
Females N= 148 Males N= 397 P-Value
Laboratory tests Value: Mean ± SD (reference range) Value: Mean ± SD (reference range)
Fasting glucose (mmol/L) 8.3 ± 4.2 (3.90–6.0) 9.9 ± 4.9 (3.90–6.0 mmol/l) NS
Hemoglobin (g/L) 12.9 ± 2.3 (12–16) 14.5 ± 2.2* (14–16 g/L) P< 0.001
WBC (white blood cell count) 7.8 ± 3.2 (4.5–11 · 109/L) 8.3 ± 3.4 (4.5–11 · 109/L) NS
Total cholesterol (mmol/L) 4.6 ± 1.4 (3.6–5.2) 1.8 ± 1.3 (3.6–5.2) NS
LDL (low density lipoprotein (mmol/L) 2.8 ± 1.3 (<3.38) 4.4 ± 1.3 (<3.38) NS
HDL (high density lipoprotein) mmol/L 1.1 ± 0.4 (>0.91) 0.98 ± 0.38* (>0.91) P< 0.008
Triglyceride (mmol/L) 1.6 ± 1 (0.11–2.15) 1.6 ± 1 (0.11–2.15) NS
Echocardiography
Performed 113 (76.4%) 308 (77.6) NS
Ejection fraction 50.9 ± 14 45.8 ± 14.3* P< 0.003
Presence of L.V clot 1 (0.9%) 0 (0%) NS
Left ventricular diastolic dysfunction 36 (31.9%) 90 (29.2%) NS
Valvular abnormalities 56 (49.6%) 151 (49%) NS
Coronary artery angiography
Performed 92 (62.2%) 247 (62.2%) NS
Coronary artery anatomy
Normal arteries 27 (29.3%) 22 (8.9%)* P< 0.001
Single vessel 22 (23.9%) 77 (31%) NS
Multi-vessels 43 (46.7%) 149 (60.3%)* P< 0.027
* Statistically signiﬁcant difference between males and females (P< 0.05).
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in-hospital mortality or re-infarction rates were observed.
4. Discussion
Many studies showed that female patients with acute coronary
syndrome (ACS) tend to be older than male patients (Dey
et al., 2009; El-Menyar et al., 2009). Which is consistent with
our ﬁnding; this is likely due to loss of the protective effect
of female hormones with aging.
In our study, the distribution of coronary risk factors was
similar in both gender groups regarding diabetes and hyperten-
sion. History of smoking, hyperlipidemia and family history of
IHD, however, were signiﬁcantly less in female patients com-
pared to males. The smoking rate difference is likely due to
the local Saudi conservative socio-cultural environment. Simi-
lar ﬁnding was reported in other international studies (McS-
weeney et al., 2003).Our ﬁndings do not agree with those reported in Gulf
RACE (El-Menyar et al., 2009) regarding the distribution of
coronary risk factors among both genders; where they re-
ported that the prevalence of diabetes, hypertension and
hyperlipidemia to be signiﬁcantly higher in women with
ACS. This discrepancy in ﬁndings could be related to the alti-
tude effect: our cohort is living in both high and low altitude
regions, and we don’t have sufﬁcient data on the distribution
of our cohort for both genders regarding the altitude location
distribution. Recent data showed signiﬁcant differences among
high and low altitude regions regarding coronary risk factors’
distributions (Al-Huthi et al., 2006). Another reason for this
discrepancy could be attributed to the relatively small sample
size in our series.
Female patients with ACS tend to present more with atyp-
ical symptoms and with more unstable angina and less ST-ele-
vation myocardial infarction, this relation of sex to type of
ACS at presentation was observed in our series and also was
Table 4 Different treatment modalities used.
Female N= 148 Male N= 397 P-Value
Thrombolytic therapy
Indicated 28 (18.9%) 162 (40.8%) NS
Given 20 (71.4%) 120 (74.1%) NS
Reperfusion 14 (70%) 97 (80.8%) NS
Complications 2 (10%) 11 (9.2%) NS
Lipid lowering therapy 130 (87.8%) 355 (89.4%) NS
Beta blockers 113 (76.4%) 268 (67.5%)* P< 0.045
Aspirin 145 (98%) 391 (98.5%) NS
Clopidogrel 115 (77.7%) 336 (84.6%) NS
ACEI 82 (55.4%) 243 (61.2%) NS
Heparin 135 (91.2%) 347 (87.4%) NS
Invasive revascularization strategy: (coronary angioplasty or CABG surgery) 46 (31.1%) 170 (42.8%)* P< 0.013
In-hospital mortality rate 5 (3.4%) 20 (5%) NS
Re-infarction rate 3 (2%) 10 (2.5%) NS
* Statistically signiﬁcant difference between males and females (P< 0.05).
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Akhter et al., 2009). Differences between the sexes in coronary
syndromes could be due to differences in thrombotic and ﬁbri-
nolytic activity (Conlan et al., 1993; Tracy et al., 1992; Stegnar
and Pentek, 1993; Cucuianu et al., 1993) or differences in the
severity of coronary disease and the presence of collateral cir-
culation (Hochman et al., 1997; Krumholz et al., 1992; Johans-
son et al., 1984).
No evidence from our study of any signiﬁcant gender bias
regarding the utilization of different investigational tools,
including Echocardiography and coronary angiography.
Nonetheless, the results of these investigations were different
among both genders.
In our series hemoglobin level was signiﬁcantly lower in fe-
male patients compared to males. Lower hemoglobin level in
patients with ACS was found to be associated with adverse
in-hospital outcomes (Sabatine et al., 2005; Zeidman et al.,
2004). The reason for lower hemoglobin level in women could
be related to the physiologic reason related to menstrual cycle
blood loss. Female patients in our series had a higher level of
high density lipoprotein than males, which might have had a
positive impact on clinical outcomes.
Female patients in our series had a higher left ventricular
ejection fraction (LVEF) compared to males whichmight trans-
late into a favorable prognosis (Rallidis et al., 2008). The reason
for this ﬁnding in our study could be related to less sever disease
in females as documented by coronary angiography results.
Similar ﬁnding was reported in other studies (Anand et al.,
2005). Interestingly, having a very high LVEF (>65%) in el-
derly women with ACS is associated with worse survival and
higher rates of sudden cardiac death than an LVEF considered
to be in the reference range (Fadi et al., 2010).
The results of coronary angiography showed that female
patients in our series had higher rate of normal coronary arter-
ies or clinically insigniﬁcant atherosclerotic lesions and lower
rate of sever coronary artery disease evident by the number
of coronary arteries involved compared to male patients,
which concur with the ﬁndings of other studies (Anand
et al., 2005; Berger et al., 2009); thus supporting the notion
of a milder form of coronary artery disease in female patients.
In our study different therapeutic agents were used in sim-
ilar pattern in both sexes but women were prescribed more b-
blockers for unclear reason.Regarding the main treatment modality, our series showed
clear gender bias in utilization of invasive revascularization
procedures, where female patients were referred less commonly
to undergo invasive revascularization procedure (coronary
angioplasty or CABG surgery). Other studies have reported
that invasive revascularization treatment was consistently used
less often in female patients (Blomkalns et al., 2005; Heer et al.,
2006; Hvelplund et al., 2010). This difference could be due to
the nature of coronary artery disease in female patients (smal-
ler vessels and less sever disease) which makes the choice of
invasive revascularization less feasible, or could be due to the
presence of true gender bias which was detected by other stud-
ies (Dey et al., 2009; Blomkalns et al., 2005; Nguyen et al.,
2008; Alfredsson et al., 2007).
In this series we did not detect a signiﬁcant difference in
mortality or re-infarction rates during admission period be-
tween the two gender groups. Reports on gender related differ-
ence in mortality among ACS patients vary from different
studies, where some studies found female gender had a signif-
icant negative impact on survival (Dey et al., 2009; Aguado-
Romeo et al., 2007; El-Menyar et al., 2009; Vaccarino et al.,
2005; Radovanovic et al., 2007), while others didn’t ﬁnd this
difference in mortality (Anand et al., 2005; Hochman et al.,
1997; Perers et al., 2005; Moriel et al., 2008). The absence of
signiﬁcant mortality difference in our series is likely due to a
favorable risk proﬁle of female patients discussed earlier,
mainly favorable coronary risk factors, higher LVEF and
milder angiographic disease.5. Conclusion
This study supports the presence of gender differences regard-
ing certain demographic factors, clinical presentation, and pos-
sible gender bias in management of female patients with ACS
mainly regarding underutilization of the invasive revasculari-
zation strategy. However, this gender related differences didn’t
adversely affect the clinical outcomes, speciﬁcally in-hospital
mortality and re-infarction rates. Similar ﬁndings were re-
ported in other studies. Awareness of the presence of this gen-
der bias should alert the medical society to avoid it by proper
application of evidence based medicine regardless of the gen-
der status of the patient.
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